• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2018 - 2019年阿联酋迪拜静脉注射铁剂治疗妊娠期缺铁性贫血的疗效：一项回顾性研究

Efficacy of Intravenous Iron Infusion in Gestational Iron Deficiency Anemia in Dubai, United Arab Emirates, During 2018-2019: A Retrospective Study.

作者信息

Alfalasi Hamda A, Kausar Shabana

机构信息

Medicine, Mohammed Bin Rashid University, Dubai, ARE.

Obstetrics and Gynecology, Mediclinic City Hospital, Dubai, ARE.

出版信息

Cureus. 2024 May 13;16(5):e60185. doi: 10.7759/cureus.60185. eCollection 2024 May.

DOI:10.7759/cureus.60185
PMID:38868236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11168021/
Abstract

OBJECTIVE

The objective is to investigate the effectiveness of intravenous (IV) iron infusion in increasing hemoglobin levels in gestational iron deficiency anemia (GIDA) patients in a tertiary-care hospital in Dubai emirate, United Arab Emirates (UAE).

METHODS

This is a retrospective cohort study of GIDA patients who were exposed to IV iron infusion supplementation. Study data of 40 cases aged 25-45 in a tertiary-care hospital in the UAE between 2018 and 2019 were analyzed. Variables accounted for were maternal age, age of gestation when IV iron was administered, and IV iron dose.

RESULTS

The average hemoglobin level before the intervention was 9 g/dL, and the average change after the intervention was 10.4 g/dL with a mean of 1.4 g/dL difference between before and after the intervention.

CONCLUSION

Supplementation of IV iron infusion in GIDA patients was seen to have increased the hemoglobin level after the intervention; however, the increase did not meet the recommended range of 12-16 g/dL.

摘要

目的

旨在研究在阿拉伯联合酋长国迪拜酋长国一家三级医疗医院中，静脉注射铁剂对改善妊娠缺铁性贫血（GIDA）患者血红蛋白水平的有效性。

方法

这是一项针对接受静脉注射铁剂补充治疗的GIDA患者的回顾性队列研究。分析了2018年至2019年期间阿联酋一家三级医疗医院中40例年龄在25至45岁之间的患者的研究数据。考虑的变量包括产妇年龄、静脉注射铁剂时的孕周以及静脉注射铁剂的剂量。

结果

干预前平均血红蛋白水平为9g/dL，干预后平均变化为10.4g/dL，干预前后平均差值为1.4g/dL。

结论

GIDA患者静脉注射铁剂补充治疗后血红蛋白水平有所提高；然而，升高幅度未达到推荐的12 - 16g/dL范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/11168021/98a2a70c3259/cureus-0016-00000060185-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/11168021/03d21425d427/cureus-0016-00000060185-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/11168021/ac5452c73f27/cureus-0016-00000060185-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/11168021/98a2a70c3259/cureus-0016-00000060185-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/11168021/03d21425d427/cureus-0016-00000060185-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/11168021/ac5452c73f27/cureus-0016-00000060185-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/11168021/98a2a70c3259/cureus-0016-00000060185-i03.jpg

相似文献

1
Efficacy of Intravenous Iron Infusion in Gestational Iron Deficiency Anemia in Dubai, United Arab Emirates, During 2018-2019: A Retrospective Study.2018 - 2019年阿联酋迪拜静脉注射铁剂治疗妊娠期缺铁性贫血的疗效：一项回顾性研究
Cureus. 2024 May 13;16(5):e60185. doi: 10.7759/cureus.60185. eCollection 2024 May.
2
Hospital-Based Prevalence of Iron Deficiency Anemia among Pre-School Children in Dubai.迪拜学龄前儿童缺铁性贫血的医院患病率
Cureus. 2020 Oct 11;12(10):e10894. doi: 10.7759/cureus.10894.
3
Intravenous versus Oral Iron for Iron-Deficiency Anemia in Pregnancy (IVIDA): A Randomized Controlled Trial.静脉铁与口服铁治疗妊娠期缺铁性贫血（IVIDA）的随机对照试验。
Am J Perinatol. 2022 Jun;39(8):808-815. doi: 10.1055/s-0041-1740003. Epub 2021 Nov 28.
4
Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.低分子右旋糖酐铁总剂量输注治疗妊娠期缺铁性贫血的疗效及安全性
J Coll Physicians Surg Pak. 2008 Jul;18(7):424-7.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区，服用抗叶酸抗疟药物的人群中，叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women.REGAIN研究：评估羧基麦芽糖铁治疗孕妇缺铁性贫血有效性、耐受性和安全性的回顾性研究。
Anemia. 2019 Nov 12;2019:4640635. doi: 10.1155/2019/4640635. eCollection 2019.
7
Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.比较研究——蔗糖铁静脉注射与山梨醇铁肌肉注射治疗妊娠缺铁性贫血的疗效、安全性及依从性
J Pak Med Assoc. 2002 Sep;52(9):392-5.
8
The Effects of Intravenous Iron Infusion on Preoperative Hemoglobin Concentration in Iron Deficiency Anemia: Retrospective Observational Study.静脉注射铁剂对缺铁性贫血患者术前血红蛋白浓度的影响：回顾性观察研究
Interact J Med Res. 2022 Feb 3;11(1):e31082. doi: 10.2196/31082.
9
Optimal Oral Iron Therapy for Iron Deficiency Anemia Among US Veterans.美国退伍军人缺铁性贫血的最佳口服铁治疗。
JAMA Netw Open. 2024 May 1;7(5):e2414305. doi: 10.1001/jamanetworkopen.2024.14305.
10
A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.一项静脉注射羧基麦芽糖铁与静脉注射多糖铁复合物或口服硫酸亚铁治疗妊娠期缺铁性贫血的前瞻性随机对照试验。
Semin Hematol. 2018 Oct;55(4):223-234. doi: 10.1053/j.seminhematol.2018.04.006. Epub 2018 Apr 25.

本文引用的文献

1
Assessment of adherence to iron supplementation among pregnant women in the Yaounde gynaeco-obstetric and paediatric hospital.雅温得妇产科和儿科医院孕妇铁补充剂依从性评估
Pan Afr Med J. 2019 Dec 26;34:211. doi: 10.11604/pamj.2019.34.211.16446. eCollection 2019.
2
REGAIN STUDY: Retrospective Study to Assess the Effectiveness, Tolerability, and Safety of Ferric Carboxymaltose in the Management of Iron Deficiency Anemia in Pregnant Women.REGAIN研究：评估羧基麦芽糖铁治疗孕妇缺铁性贫血有效性、耐受性和安全性的回顾性研究。
Anemia. 2019 Nov 12;2019:4640635. doi: 10.1155/2019/4640635. eCollection 2019.
3
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.
妊娠期间用静脉注射羧基麦芽糖铁治疗缺铁和缺铁性贫血。
Arch Gynecol Obstet. 2018 Dec;298(6):1231-1232. doi: 10.1007/s00404-018-4943-x. Epub 2018 Oct 22.
4
Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report.孕期及产后缺铁性贫血的诊断与治疗：缺铁性贫血工作组共识报告
Turk J Obstet Gynecol. 2015 Sep;12(3):173-181. doi: 10.4274/tjod.01700. Epub 2015 Sep 15.
5
Maternal mortality and the role of the obstetric anesthesiologist.孕产妇死亡率与产科麻醉医生的作用
Best Pract Res Clin Anaesthesiol. 2017 Mar;31(1):91-105. doi: 10.1016/j.bpa.2017.01.005. Epub 2017 Feb 3.
6
Improving health outcomes through patient education and partnerships with patients.通过患者教育以及与患者建立伙伴关系来改善健康状况。
Proc (Bayl Univ Med Cent). 2017 Jan;30(1):112-113. doi: 10.1080/08998280.2017.11929552.
7
Methodology Series Module 1: Cohort Studies.方法学系列模块1：队列研究。
Indian J Dermatol. 2016 Jan-Feb;61(1):21-5. doi: 10.4103/0019-5154.174011.
8
The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial.静脉铁剂在腹部大手术围手术期患者血液管理中的重要作用：一项随机对照试验
Ann Surg. 2016 Jul;264(1):41-6. doi: 10.1097/SLA.0000000000001646.
9
Safety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control Study.羧基麦芽糖铁在贫血孕妇中的安全性和有效性：一项回顾性病例对照研究
Obstet Gynecol Int. 2015;2015:728952. doi: 10.1155/2015/728952. Epub 2015 Nov 24.
10
International caesarean section rates: the rising tide.国际剖宫产率：不断上升的趋势。
Lancet Glob Health. 2015 May;3(5):e241-2. doi: 10.1016/S2214-109X(15)70111-7. Epub 2015 Apr 9.